Search for Clinical Trial Results
Angioimmunoblastic T-cell Lymphoma - 244 Studies Found
Status | Study |
Completed |
Study Name: Oxaliplatin in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma Condition:
|
Terminated |
Study Name: 506U78 in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma or T-cell Lymphoma Condition:
|
Completed |
Study Name: Study of Bortezomib and Panobinostat in Treating Patients With Relapsed/Refractory Peripheral T-cell Lymphoma or NK/T-cell Lymphoma Condition:
|
Recruiting |
Study Name: A Phase II Study of Single Agent Brentuximab Vedotin in Relapsed/Refractory CD30 Low (<10%) Mature T Cell Lymphoma (TCL) Condition:
Interventions: Drug: Brentuximab vedotin study drug given intravenously to determine efficacy in study diseases |
Completed |
Study Name: 3-AP and Gemcitabine in Treating Patients With Advanced Solid Tumors or Lymphoma Condition:
|
Completed |
Study Name: Sorafenib Tosylate in Treating Patients With Recurrent Aggressive Non-Hodgkin's Lymphoma Condition:
|
Completed |
Study Name: 17-DMAG in Treating Patients With Metastatic or Unresectable Solid Tumors or Lymphomas Condition:
|
Completed |
Study Name: 506U78 in Treating Patients With Lymphoma Condition:
|
Recruiting |
Study Name: Romidepsin and Lenalidomide in Treating Patients With Previously Untreated Peripheral T-Cell Lymphoma Condition:
Interventions: |
Recruiting |
Study Name: Cholecalciferol in Improving Survival in Patients With Newly Diagnosed Cancer With Vitamin D Insufficiency Condition:
|